The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.20
Bid: 182.40
Ask: 182.60
Change: 0.00 (0.00%)
Spread: 0.20 (0.11%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 182.20
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of the sale of Filters business

5 Dec 2022 10:31

RNS Number : 6032I
Essentra plc
05 December 2022
 

 

ESSENTRA PLC

 

Completion of the sale of Filters

 

 

Further to the announcement on 3 October 2022, Essentra plc ("the Company" or "Essentra"), a leading global provider of essential components and solutions, is pleased to confirm, following receipt of shareholder approval, the successful completion of the disposal of Essentra Filter Holdings Limited ("Filters") to Frank Acquisition Four Limited, a wholly owned subsidiary of Centaury Management Limited.

 

 

 

 

Investor enquiries:

Essentra plc

Jack Clarke, Chief Financial Officer

Claire Goodman, Group Investor Relations Manager

Tel: +44 (0)1908 359100

Media enquiries:

Tulchan Communications LLP

Olivia Peters

Lisa Jarrett-Kerr

Tel: +44 (0)20 7353 4200

 

Important information relating to financial advisers

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Essentra plc as sponsor and for no one else in connection with the transaction and will not be responsible to anyone other than Essentra plc for providing the protections afforded to clients of Peel Hunt or for providing advice in relation to in this announcement. Apart from the responsibilities and liabilities, if any, which may be imposed upon Peel Hunt by FSMA or the regulatory regime established thereunder, Peel Hunt and its subsidiaries, branches and affiliates, and such entities' respective directors, officers, employees and agents do not accept any duty, responsibility or liability whatsoever or make any representation or warranty, express or implied, concerning the contents of this announcement, including its accuracy, completeness or verification, or concerning any other statement made or purported to be made by it, or on its behalf, in connection with Essentra plc or the transaction, and nothing in this announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or future. Peel Hunt accordingly disclaims, to the fullest extent permitted by law, all and any responsibility and liability whether arising in tort, contract or otherwise (save as referred to above) which it might otherwise have in respect of this announcement, or any such statement.

Goldman Sachs International ("Goldman Sachs"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively as financial adviser to the Board of Essentra plc and no one else in connection with the transaction and will not be responsible to anyone other than the Board of Essentra plc for providing the protections afforded to clients of Goldman Sachs nor for providing advice in relation to the transaction or any other matters referred to in this announcement. Neither Goldman Sachs nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goldman Sachs in connection with the transaction, this announcement, any statement contained herein or otherwise.

Lazard & Co., Limited ("Lazard"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as financial adviser to the Board of Essentra plc and no one else in connection with the transaction and will not be responsible to anyone other than the Board of Essentra plc for providing the protections afforded to clients of Lazard, nor for providing advice to any other person in relation to the transaction or any other matters referred to in this announcement. Neither Lazard nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard in connection with this announcement, any statement contained herein or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISBELFBLLLLFBK
Date   Source Headline
3rd May 202411:32 amRNSTransaction in Own Shares
3rd May 202411:26 amRNSTransaction in Own Shares - Correction
3rd May 202411:17 amRNSTransaction in Own Shares - Correction
3rd May 202411:12 amRNSTransaction in Own Shares - Correction
3rd May 202411:06 amRNSTransaction in Own Shares - Correction
3rd May 202411:02 amRNSTransaction in Own Shares - Correction
3rd May 202410:58 amRNSTransaction in Own Shares - Correction
3rd May 202410:53 amRNSTransaction in Own Shares - Correction
3rd May 202410:46 amRNSTransaction in Own Shares - Correction
3rd May 202410:36 amRNSTransaction in Own Shares - Correction
3rd May 202410:26 amRNSTransaction in Own Shares
3rd May 202410:22 amRNSTransaction in Own Shares - Correction
3rd May 202410:06 amRNSTransaction in Own Shares - Correction
3rd May 20249:59 amRNSTransaction in Own Shares - Correction
3rd May 20249:54 amRNSTransaction in Own Shares - Correction
3rd May 20249:47 amRNSTransaction in Own Shares - Correction
3rd May 20249:30 amRNSTransaction in Own Shares - Correction
2nd May 20249:44 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20247:45 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20241:57 pmRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20242:28 pmRNSDirector/PDMR Shareholding
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20241:35 pmRNSDirector/PDMR Shareholding
5th Apr 20241:35 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20242:08 pmRNSDirector/PDMR Shareholding
4th Apr 202411:00 amRNSNotice of AGM
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 202411:26 amRNSTransaction in Own Shares
2nd Apr 20242:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20244:18 pmRNSPublication of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.